NCCN Guidelines® Insights - Survivorship, Version 1.2023 |
1.00 |
08/10/2023 - 12:00am to 08/10/2024 - 12:00am |
Acute Myeloid Leukemia Patient Management Simulator |
|
08/10/2023 - 12:00am to 08/09/2024 - 12:00am |
Unlocking the Potential of Neoadjuvant and Adjuvant Immunotherapy in Resectable NSCLC: The Role of Checkpoint Inhibitors |
1.75 |
08/09/2023 - 12:00am to 08/09/2024 - 12:00am |
The Evolving Landscape in CLL/SLL: Best Practice Clinical Applications of Current Evidence and New Guideline Recommendations |
1.75 |
07/21/2023 - 12:00am to 07/21/2024 - 12:00am |
Advances in Hepatocellular and Biliary Tract Cancers Impacting Patient Outcomes |
1.75 |
07/21/2023 - 12:00am to 07/21/2024 - 12:00am |
Clinical Considerations in Renal Cell Carcinoma: Current Evidence, Guideline Recommendations, and a View to the Future |
1.75 |
07/21/2023 - 12:00am to 07/21/2024 - 12:00am |
NCCN Guidelines® Insights - Biliary Tract Cancers, Version 2.2023 |
1.00 |
07/10/2023 - 12:00am to 07/10/2024 - 12:00am |
Recorded Presentation from the NCCN Pharmacy Updates: Updates on Targeted Therapy for the Treatment of Thyroid Carcinoma |
1.00 |
06/30/2023 - 12:00am to 06/28/2024 - 12:00am |
Archived Monthly Oncology Tumor Boards: Advances in Systemic Treatment of Metastatic Cutaneous Melanoma |
1.00 |
06/29/2023 - 12:00am to 06/29/2024 - 12:00am |
Monthly Oncology Tumor Boards: Management of Pheochromocytoma and Paraganglioma |
1.00 |
06/29/2023 - 12:00am to 07/21/2024 - 12:00am |
What is Biomarker Testing, and Why Is It Important? |
1.00 |
06/15/2023 - 12:00am to 06/15/2024 - 12:00am |
Evaluating Immune Checkpoint Inhibition Response Biomarkers |
0.75 |
06/15/2023 - 12:00am to 06/15/2024 - 12:00am |
Clinical Scenario #1: Applying Biomarkers in Risk Stratification of Localized Prostate Cancer |
0.75 |
06/15/2023 - 12:00am to 06/15/2024 - 12:00am |
Clinical Scenario #2: Applying Biomarkers in Breast Cancer |
0.75 |
06/15/2023 - 12:00am to 06/15/2024 - 12:00am |
Clinical Scenario #3: Applying Biomarkers in Central Nervous System Cancers |
0.75 |
06/15/2023 - 12:00am to 06/15/2024 - 12:00am |